AUROPHARMAPharmaceuticals
Aurobindo Pharma Ltd — Balance Sheet
₹1304.40
+0.49%
Aurobindo Pharma Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 58.08 Cr | 58.59 Cr | 58.59 Cr | 58.59 Cr | — |
| Share Issued | 58.08 Cr | 58.59 Cr | 58.59 Cr | 58.59 Cr | — |
| Net Debt | 2.37K Cr | 2.92K Cr | 465.23 Cr | — | — |
| Total Debt | 8.26K Cr | 6.65K Cr | 5.29K Cr | 3.28K Cr | — |
| Tangible Book Value | 28.41K Cr | 25.77K Cr | 22.92K Cr | 20.96K Cr | — |
| Invested Capital | 40.59K Cr | 36.16K Cr | 31.70K Cr | 27.38K Cr | — |
| Working Capital | 12.48K Cr | 12.01K Cr | 10.05K Cr | 9.97K Cr | — |
| Net Tangible Assets | 28.41K Cr | 25.77K Cr | 22.92K Cr | 20.96K Cr | — |
| Capital Lease Obligations | 321.19 Cr | 332.41 Cr | 424.69 Cr | 478.50 Cr | — |
| Common Stock Equity | 32.65K Cr | 29.84K Cr | 26.84K Cr | 24.58K Cr | — |
| Total Capitalization | 34.21K Cr | 31.98K Cr | 27.46K Cr | 24.83K Cr | — |
| Total Equity Gross Minority Interest | 32.65K Cr | 29.85K Cr | 26.85K Cr | 24.57K Cr | — |
| Minority Interest | -6.39 Cr | 8.00 Cr | 12.00 Cr | -1.93 Cr | — |
| Stockholders Equity | 32.65K Cr | 29.84K Cr | 26.84K Cr | 24.58K Cr | — |
| Other Equity Interest | 32.60K Cr | 29.78K Cr | 26.78K Cr | 24.52K Cr | — |
| Capital Stock | 58.08 Cr | 58.59 Cr | 58.59 Cr | 58.59 Cr | — |
| Common Stock | 58.08 Cr | 58.59 Cr | 58.59 Cr | 58.59 Cr | — |
| Total Liabilities Net Minority Interest | 17.14K Cr | 15.22K Cr | 13.04K Cr | 9.35K Cr | — |
| Total Non Current Liabilities Net Minority Interest | 2.46K Cr | 3.02K Cr | 1.54K Cr | 1.19K Cr | — |
| Other Non Current Liabilities | 54.54 Cr | 36.47 Cr | -1.52K Cr | 29.77 Cr | — |
| Non Current Deferred Taxes Liabilities | 303.27 Cr | 356.56 Cr | 389.61 Cr | 410.96 Cr | — |
| Long Term Debt And Capital Lease Obligation | 1.80K Cr | 2.39K Cr | 940.49 Cr | 567.82 Cr | — |
| Long Term Capital Lease Obligation | 239.21 Cr | 252.53 Cr | 321.53 Cr | 318.61 Cr | — |
| Long Term Debt | 1.56K Cr | 2.13K Cr | 618.96 Cr | 249.21 Cr | — |
| Long Term Provisions | 282.93 Cr | 225.70 Cr | 172.72 Cr | 171.79 Cr | — |
| Current Liabilities | 14.68K Cr | 12.20K Cr | 11.49K Cr | 8.16K Cr | — |
| Other Current Liabilities | 546.83 Cr | 280.33 Cr | 223.59 Cr | 127.94 Cr | — |
| Current Debt And Capital Lease Obligation | 6.46K Cr | 4.26K Cr | 4.35K Cr | 2.71K Cr | — |
| Current Capital Lease Obligation | 81.98 Cr | 79.88 Cr | 103.16 Cr | 159.89 Cr | — |
| Current Debt | 6.38K Cr | 4.18K Cr | 4.24K Cr | 2.55K Cr | — |
| Current Provisions | 275.56 Cr | 256.79 Cr | 200.53 Cr | 170.56 Cr | — |
| Payables | 4.47K Cr | 5.56K Cr | 4.76K Cr | 3.39K Cr | — |
| Total Tax Payable | 284.93 Cr | 249.01 Cr | 211.60 Cr | 58.03 Cr | — |
| Accounts Payable | 4.19K Cr | 4.45K Cr | 3.87K Cr | 2.70K Cr | — |
| Total Assets | 49.78K Cr | 45.07K Cr | 39.89K Cr | 33.92K Cr | — |
| Total Non Current Assets | 22.62K Cr | 20.87K Cr | 18.34K Cr | 15.80K Cr | — |
| Other Non Current Assets | 293.85 Cr | 229.96 Cr | 4.53 Cr | 0.01 Cr | — |
| Non Current Deferred Taxes Assets | 1.29K Cr | 1.21K Cr | 677.49 Cr | 288.59 Cr | — |
| Investmentin Financial Assets | 743.87 Cr | 151.61 Cr | 228.16 Cr | 332.74 Cr | — |
| Available For Sale Securities | 743.87 Cr | 47.12 Cr | 61.86 Cr | 91.59 Cr | — |
| Long Term Equity Investment | 45.54 Cr | 170.05 Cr | 168.36 Cr | 285.56 Cr | — |
| Goodwill And Other Intangible Assets | 4.24K Cr | 4.08K Cr | 3.92K Cr | 3.61K Cr | — |
| Other Intangible Assets | 3.62K Cr | 3.48K Cr | 3.33K Cr | 3.14K Cr | — |
| Goodwill | 618.02 Cr | 595.15 Cr | 596.07 Cr | 475.42 Cr | — |
| Net PPE | 15.46K Cr | 14.41K Cr | 12.80K Cr | 10.77K Cr | — |
| Gross PPE | 15.46K Cr | 20.78K Cr | 18.36K Cr | 14.64K Cr | — |
| Construction In Progress | 3.27K Cr | 2.87K Cr | 4.81K Cr | 3.04K Cr | — |
| Other Properties | 12.19K Cr | 11.55K Cr | 8.00K Cr | 699.26 Cr | — |
| Current Assets | 27.16K Cr | 24.21K Cr | 21.55K Cr | 18.12K Cr | — |
| Other Current Assets | 2.36K Cr | 2.54K Cr | 1.87K Cr | 1.56K Cr | — |
| Assets Held For Sale Current | 0.00 | 433.71 Cr | 85.76 Cr | 79.10 Cr | — |
| Inventory | 10.54K Cr | 9.81K Cr | 8.51K Cr | 7.55K Cr | — |
| Other Receivables | 15.56 Cr | 527.84 Cr | 548.00 Cr | 374.64 Cr | — |
| Taxes Receivable | 2.78 Cr | 5.67 Cr | 75.62 Cr | 269.99 Cr | — |
| Accounts Receivable | 5.75K Cr | 4.82K Cr | 4.47K Cr | 4.01K Cr | — |
| Cash Cash Equivalents And Short Term Investments | 8.50K Cr | 6.33K Cr | 6.22K Cr | 4.56K Cr | — |
| Other Short Term Investments | 2.93K Cr | 2.93K Cr | 1.83K Cr | 395.13 Cr | — |
| Cash And Cash Equivalents | 5.57K Cr | 3.39K Cr | 4.40K Cr | 4.16K Cr | — |
| Retained Earnings | — | 26.80K Cr | 24.01K Cr | 22.52K Cr | 20.14K Cr |
| Additional Paid In Capital | — | 529.51 Cr | 426.89 Cr | 426.89 Cr | 426.89 Cr |
| Non Current Pension And Other Postretirement Benefit Plans | — | 225.70 Cr | 172.72 Cr | 171.79 Cr | 157.11 Cr |
| Tradeand Other Payables Non Current | — | 0.12 Cr | 29.04 Cr | 29.77 Cr | 39.50 Cr |
| Non Current Deferred Revenue | — | 36.35 Cr | 0.00 | — | — |
| Current Deferred Taxes Liabilities | — | 249.01 Cr | 211.60 Cr | 58.03 Cr | 210.35 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 256.79 Cr | 200.53 Cr | 170.56 Cr | 171.93 Cr |
| Other Payable | — | 1.11K Cr | 881.66 Cr | 681.35 Cr | 853.50 Cr |
| Dividends Payable | — | 3.02 Cr | 2.49 Cr | 2.57 Cr | 2.60 Cr |
| Defined Pension Benefit | — | 1.08 Cr | 4.53 Cr | — | — |
| Non Current Prepaid Assets | — | 581.93 Cr | 476.61 Cr | 146.12 Cr | 509.84 Cr |
| Held To Maturity Securities | — | 89.34 Cr | 151.15 Cr | — | — |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | — | 15.15 Cr | 15.15 Cr | 15.15 Cr | 15.15 Cr |
| Investmentsin Joint Venturesat Cost | — | 160.33 Cr | 158.79 Cr | 274.80 Cr | 262.07 Cr |
| Investmentsin Associatesat Cost | — | 9.72 Cr | 9.57 Cr | 10.76 Cr | — |
| Accumulated Depreciation | — | -6.37K Cr | -5.56K Cr | -3.87K Cr | -3.15K Cr |
| Machinery Furniture Equipment | — | 12.02K Cr | 9.01K Cr | 7.97K Cr | 6.75K Cr |
| Buildings And Improvements | — | 4.92K Cr | 3.59K Cr | 2.84K Cr | 2.42K Cr |
| Land And Improvements | — | 978.65 Cr | 954.52 Cr | 781.18 Cr | 286.01 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Hedging Assets Current | — | 3.45 Cr | 19.14 Cr | 32.02 Cr | 19.82 Cr |
| Restricted Cash | — | 3.71 Cr | 11.57 Cr | 11.22 Cr | 12.87 Cr |
| Prepaid Assets | — | 2.29K Cr | 1.68K Cr | 1.23K Cr | 965.00 Cr |
| Inventories Adjustments Allowances | — | -2.24 Cr | -4.88 Cr | — | — |
| Other Inventories | — | 468.33 Cr | 378.48 Cr | 340.27 Cr | 354.98 Cr |
| Finished Goods | — | 4.56K Cr | 3.73K Cr | 3.35K Cr | 4.12K Cr |
| Work In Process | — | 1.58K Cr | 1.41K Cr | 1.20K Cr | 1.30K Cr |
| Raw Materials | — | 3.20K Cr | 3.00K Cr | 2.66K Cr | 3.25K Cr |
| Allowance For Doubtful Accounts Receivable | — | -123.25 Cr | -121.66 Cr | -92.13 Cr | -94.99 Cr |
| Gross Accounts Receivable | — | 4.94K Cr | 4.59K Cr | 4.10K Cr | 3.60K Cr |
| Cash Equivalents | — | 2.01K Cr | 2.59K Cr | 629.72 Cr | 0.65 Cr |
| Cash Financial | — | 1.38K Cr | 1.80K Cr | 3.53K Cr | 5.37K Cr |
| Trading Securities | — | — | 151.15 Cr | 226.00 Cr | 154.00 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Aurobindo Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.